Note 5 - Stock-Based Compensation

Stock-based compensation includes stock options, cash-settled stock appreciation rights (SARs) and restricted stock awards. Additionally, we recognize stock-based compensation expense for the discount on shares sold to employees through our employee stock purchase plan. For the thirteen and thirty-nine weeks ended October 31, 2015, stock-based compensation expense for the employee stock purchase plan was $9,000 before the income tax benefit of $3,000 and $32,000 before the income tax benefit of $12,000, respectively. For the thirteen and thirty-nine weeks ended November 1, 2014, stock-based compensation expense for the employee stock purchase plan was $8,000 before the income tax benefit of $3,000 and $28,000 before the income tax benefit of $11,000, respectively.

The following table summarizes the share transactions for our restricted stock awards:

	Number of Shares			Weighted- Average Grant Date Fair Value
Restricted stock at January 31, 2015		705,576		$	21.49
Granted		212,503			24.43
Vested		(4,750	)		22.30
Forfeited		(69,056	)		21.98
Restricted stock at October 31, 2015		844,273		$	22.18

The weighted-average grant date fair value of stock awards granted during the thirty-nine week periods ended October 31, 2015 and November 1, 2014 was $24.43 and $25.55, respectively. The total fair value at grant date of previously non-vested stock awards that vested during the first nine months of fiscal 2015 was $106,000. The total fair value at grant date of previously non-vested stock awards that vested during the first nine months of fiscal 2014 was $54,000.

The following section summarizes information regarding stock-based compensation expense recognized for restricted stock awards:

(In thousands)	Thirteen Weeks Ended October 31, 2015		Thirteen Weeks Ended November 1, 2014		Thirty-nine Weeks Ended October 31, 2015		Thirty-nine Weeks Ended November 1, 2014
Stock-based compensation expense before the recognized income tax benefit	$	810	$	(1,555)	$	2,344	$	259
Income tax benefit	$	308	$	(608)	$	902	$	102

During the third quarter of fiscal 2014, we recognized a $1.6 million reduction in expense, which was comprised of stock-based compensation expense of $732,000 offset by an expense reversal of $2.3 million. The reduction in expense was attributable to our reversal of cumulative prior period expense for performance-based awards, which management deemed as not probable of vesting prior to their expiration.

As of October 31, 2015, approximately $9.7 million of unrecognized compensation expense remained related to both our performance-based and service-based restricted stock awards. The cost is expected to be recognized over a weighted average period of approximately 2.8 years. This incorporates our current assumptions with respect to the estimated requisite service period required to achieve the designated performance conditions for performance-based stock awards.

The following table summarizes the SARs activity:

	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)
Outstanding at January 31, 2015		40,375		$	17.17
Granted		156,175			24.26
Forfeited		(2,625	)		24.26
Exercised		(40,375	)		17.17
Outstanding at October 31, 2015		153,550		$	24.26		4.38

SARs were granted during the first quarter of fiscal 2015 to certain non-executive employees, such that one-third of the shares underlying the SARs will vest and become fully exercisable on each of the first three anniversaries of the date of the grant and were assigned a five-year term from the date of grant, after which any unexercised SARs will expire. These SARs granted during the first quarter of fiscal 2015 were issued with a defined maximum gain of $10.00 over the exercise price of $24.26. The SARs exercised in the first quarter of fiscal 2015 were the remaining outstanding SARs granted in the first quarter of fiscal 2012.

The fair value of these liability awards are remeasured, using a trinomial lattice model, at each reporting period until the date of settlement. Increases or decreases in stock-based compensation expense are recognized over the vesting period, or immediately for vested awards. The weighted-average fair value of outstanding, non-vested SAR awards was $ 3.70 as of October 31, 2015.

The following table summarizes information regarding stock-based compensation expense recognized for SARs:

(In thousands)	Thirteen Weeks Ended October 31, 2015		Thirteen Weeks Ended November 1, 2014		Thirty-nine Weeks Ended October 31, 2015		Thirty-nine Weeks Ended November 1, 2014
Stock-based compensation expense before the recognized income tax benefit	$	24	$	26	$	219	$	5
Income tax benefit	$	9	$	10	$	84	$	2

As of October 31, 2015, approximately $358,000 in unrecognized compensation expense remained related to non-vested SARs. This expense is expected to be recognized over a weighted-average period of approximately 1.42 years.